Not yet recruiting NCT06573827
— Observational Czechia
Urinary Tract Infections
Not yet recruiting NCT06573736
— Observational —
Prostate Cancer
Recruiting NCT06325774
No phase Interventional China
Localized Prostate Cancer
Recruiting NCT06279260
— Observational Australia
Database · Prostate Cancer · Robotic-assisted Radical Prostatectomy
Recruiting NCT06325995
No phase Interventional China
Localized Prostate Cancer
Recruiting NCT06548529
No phase Interventional China
HER2 Positive or Suspicious Positive Tumors
Not yet recruiting NCT06564220
— Observational —
Testicular Adrenal Rest Tumor · Congenital Adrenal Hyperplasia
Recruiting NCT06564415
— Observational Italy
Benign Prostatic Hyperplasia · Prostatic Diseases
Recruiting NCT05024162
No phase Interventional Canada
Prostate Cancer
Recruiting NCT06215976
Phase IV Interventional Egypt
Muscle-Invasive Bladder Carcinoma
Enrolling by invitation NCT06563193
— Observational Turkey (Türkiye)
Overactive Bladder
Not yet recruiting NCT06336564
No phase Interventional Brazil
Menopause · Urinary Incontinence
Not yet recruiting NCT06558370
No phase Interventional Egypt
Hysteroscopy
Not yet recruiting NCT06524219
— Observational —
Prostate Cancer
Recruiting NCT05221021
Phase IV Interventional United States
Overactive Bladder Syndrome
Recruiting NCT04271527
No phase Interventional China
Prostate Cancer
Not yet recruiting NCT06558539
Phase III Interventional —
Persistent Overactive Bladder Symptoms Post Benign Prostatic Hyperplasia Surgery
Recruiting NCT06362577
— Observational China
Localized Prostate Cancer
Recruiting NCT05646745
No phase Interventional Egypt
Stress Urinary Incontinence
Not yet recruiting NCT06554249
No phase Interventional Egypt
Contraceptive Device
Recruiting NCT05647070
No phase Interventional Egypt
Stress Urinary Incontinence
Recruiting NCT01890590
No phase Interventional United States
Renal Cell Carcinoma
Recruiting NCT06553469
— Observational China
Cystometry · Sacral Neuromodulation · Ultrasound
Recruiting NCT06343038
Phase I Interventional Switzerland
Castration-resistant Prostate Cancer
Recruiting NCT06553339
Phase I Interventional China
Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
Not yet recruiting NCT06550947
— Observational —
Bladder Urothelial Carcinoma
Recruiting NCT06551233
Phase I Interventional China
Bladder Cancer
Recruiting NCT05232136
Phase I / Phase II Interventional China
Non-muscle-invasive Bladder Cancer
Not yet recruiting NCT06548438
Phase IV Interventional —
Bladder Cancer
Recruiting NCT06548867
— Observational Italy
Metastatic Renal Cell Carcinoma
Recruiting NCT06546865
No phase Interventional Canada
Benign Prostatic Hyperplasia
Not yet recruiting NCT06546527
Early Phase I Interventional —
Prostate Cancer
Recruiting NCT06543420
No phase Interventional China
Prostate Cancer
Enrolling by invitation NCT06541821
— Observational Turkey (Türkiye)
Bladder Cancer
Recruiting NCT04995198
— Observational United States
Prostate Cancer
Recruiting NCT06536725
— Observational China
Prostate Cancer · Organoid
Recruiting NCT06537037
— Observational China
Urologic Cancer
Not yet recruiting NCT06505278
Phase II Interventional China
Prostate Cancer
Recruiting NCT06311110
— Observational Belgium
Developmental Coordination Disorder · Lower Urinary Tract Symptoms · Bowel Dysfunction
Recruiting NCT06529549
— Observational China
Metastatic Castration-resistant Prostate Cancer
Not yet recruiting NCT06528483
Phase II Interventional Italy
Bladder Cancer · Bladder Urothelial Carcinoma · Bladder Neoplasm
Not yet recruiting NCT06523049
Phase II Interventional China
Renal Cell Carcinoma · Immunotherapy · Molecular Targeted Therapy
Recruiting NCT06518226
No phase Interventional Netherlands
Prostate Cancer · Prostate Adenocarcinoma · Localized Prostate Carcinoma
Not yet recruiting NCT06310369
Phase II Interventional —
Bladder Cancer
Recruiting NCT06425978
Phase IV Interventional Spain
Genitourinary Syndrome of Menopause
Not yet recruiting NCT06500247
Phase II Interventional China
The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Recruiting NCT06378242
Phase I / Phase II Interventional China
High-risk Non-muscle Invasive Bladder Cancer
Recruiting NCT06494696
— Observational Taiwan
Prostate Cancer
Recruiting NCT05618886
No phase Interventional Nepal
Urinary Incontinence
Recruiting NCT06321250
Phase I Interventional China
Renal Cell Carcinoma Metastatic
Recruiting NCT06490211
— Observational China
Urinary System Carcinoma
Recruiting NCT06491056
— Observational Singapore
Prostate Cancer
Not yet recruiting NCT06489496
— Observational —
Prostate Cancer
Not yet recruiting NCT06469229
— Observational China
Hematuria · Urothelial Carcinoma · Bladder Cancer
Recruiting NCT05352178
Phase III Interventional Belgium
Prostate Cancer · Prostate Cancer Recurrent · Prostate Cancer Metastatic
Recruiting NCT05762536
Phase II Interventional Netherlands
Metastatic Castration-resistant Prostate Cancer
Recruiting NCT06474338
— Observational China
Bladder Tumor
Not yet recruiting NCT06472752
— Observational China
Urothelial Carcinoma of the Renal Pelvis and Ureter
Recruiting NCT06473259
— Observational Italy
Prostate Cancer · Hormone Sensitive Prostate Cancer · Metastatic Tumor
Not yet recruiting NCT06472895
Phase I / Phase II Interventional —
Renal Cell Carcinoma
Recruiting NCT06461819
Phase II Interventional South Korea
Low-to-intermediate-risk Prostate Carcinoma
Recruiting NCT06461793
Phase II Interventional South Korea
High Risk Prostate Carcinoma
Recruiting NCT06467097
Phase III Interventional South Korea
Kidney Neoplasm
Recruiting NCT06464822
— Observational Hong Kong
Bariatric Surgery Candidate · Lower Urinary Tract Symptoms
Recruiting NCT05280028
— Observational Taiwan
Menopausal Syndrome
Recruiting NCT04615065
— Observational Netherlands
Acute Disease · Sepsis · Pneumonia
Recruiting NCT05814250
— Observational Italy
Urinary Tract Infections
Not yet recruiting NCT06453785
No phase Interventional United Kingdom
Prostate Cancer
Not yet recruiting NCT06452927
No phase Interventional —
Lower Urinary Tract Symptoms · Lower Urinary Tract Obstructive Syndrome · Detrusor Underactivity
Recruiting NCT05563558
Phase II Interventional Spain
Prostate Cancer Metastatic
Recruiting NCT06449664
No phase Interventional Sweden
Prostate Cancer
Recruiting NCT05709028
Phase III Interventional Australia
Urinary Tract Infections
Recruiting NCT05739968
No phase Interventional Taiwan
Bladder Cancer · Quality of Life
Not yet recruiting NCT05255692
No phase Interventional Belgium
fMRI Research
Recruiting NCT06443268
— Observational Switzerland
Quality of Life · Stroke, Acute · Sexual Behavior
Recruiting NCT06442020
No phase Interventional Italy
Erectile Dysfunction
Recruiting NCT06441110
Phase III Interventional China
Urinary Bladder Neoplasms · BCG Vaccine · Immunotherapy, Active
Enrolling by invitation NCT06437899
No phase Interventional Austria
Overactive Bladder
Not yet recruiting NCT06435702
— Observational China
Prostate Cancer
Recruiting NCT06399419
Phase I Interventional United States
Advanced Clear Cell Renal Cell Carcinoma · Advanced Renal Cell Carcinoma · Advanced Sarcomatoid Renal Cell Carcinoma
Enrolling by invitation NCT06085846
— Observational United States
Urinary Incontinence · Urinary Urge Incontinence
Not yet recruiting NCT06430411
— Observational —
Prostate Cancer Metastatic · Prostate Cancer Metastatic to Bone · Prostate Cancer
Recruiting NCT04754737
No phase Interventional United States
Antibiotic Stewardship · Overactive Bladder · Onabotulinumtoxin A
Recruiting NCT06423976
— Observational United Kingdom
Prostate Cancer
Not yet recruiting NCT06427057
Phase II Interventional —
Urinary System Tumor
Recruiting NCT04694924
— Observational Belgium
Prostate Cancer · Adenocarcinoma of the Prostate · Locally Advanced Prostate Carcinoma
Recruiting NCT06421103
No phase Interventional United Kingdom
Perfusion · Fluorescence Imaging · Gastrointestinal Tract Disorders
Recruiting NCT06224218
No phase Interventional United States
Prostate Hyperplasia
Recruiting NCT05646550
Phase I Interventional Germany
Prostate Cancer Recurrent
Recruiting NCT05397262
No phase Interventional Germany
Bladder Cancer
Recruiting NCT06397755
— Observational Italy
Prostate Cancer
Recruiting NCT05868174
Phase I Interventional Australia
Solid Tumor, Adult · Advanced Solid Tumor · Advanced Renal Cell Carcinoma
Recruiting NCT06357416
No phase Interventional United Kingdom
Prostate Cancer · Urologic Cancer · Urologic Diseases
Recruiting NCT06389409
— Observational Italy
Testicular Cancer
Recruiting NCT03749980
— Observational United States
Von Hippel-Lindau Disease · Hereditary Leiomyomatosis and Renal Cell Cancer · Birt-Hogg-Dube Syndrome
Recruiting NCT06387056
Phase II Interventional China
Locally Advanced Prostate Cancer · Oligometastatic Prostate Cancer
Recruiting NCT06260410
— Observational Netherlands
Prostate Cancer Metastatic
Recruiting NCT05709496
No phase Interventional United Kingdom
Prostate Adenocarcinoma
Recruiting NCT06373055
— Observational South Korea
Muscle-invasive Bladder Cancer
Recruiting NCT06373419
No phase Interventional Canada
Urolithiasis of Bladder